{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,24]],"date-time":"2026-04-24T04:37:01Z","timestamp":1777005421274,"version":"3.51.4"},"reference-count":54,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,3,17]],"date-time":"2026-03-17T00:00:00Z","timestamp":1773705600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,4,24]],"date-time":"2026-04-24T00:00:00Z","timestamp":1776988800000},"content-version":"vor","delay-in-days":38,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Infect Dis"],"DOI":"10.1186\/s12879-026-12922-6","type":"journal-article","created":{"date-parts":[[2026,3,17]],"date-time":"2026-03-17T11:15:38Z","timestamp":1773746138000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Alloferon regulates the growth and movement of Trichomonas vaginalis by altering hydrogenosomes"],"prefix":"10.1186","volume":"26","author":[{"given":"Hyejung","family":"Jo","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Minsoo","family":"Kang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yejin","family":"Kim","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jae Seung","family":"Kang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2026,3,17]]},"reference":[{"key":"12922_CR1","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1136\/sti.2003.005124","volume":"80","author":"H Swygard","year":"2004","unstructured":"Swygard H, Sena A, Hobbs M, Cohen M. Trichomoniasis: clinical manifestations, diagnosis and management. Sex Transm Infect. 2004;80:91\u20135.","journal-title":"Sex Transm Infect"},{"key":"12922_CR2","doi-asserted-by":"publisher","first-page":"369","DOI":"10.1016\/j.mpmed.2014.04.004","volume":"42","author":"D Lewis","year":"2014","unstructured":"Lewis D, Trichomoniasis. Medicine. 2014;42:369\u201371.","journal-title":"Medicine"},{"key":"12922_CR3","doi-asserted-by":"publisher","first-page":"548","DOI":"10.2471\/BLT.18.228486","volume":"97","author":"J Rowley","year":"2019","unstructured":"Rowley J, et al. Chlamydia, gonorrhoea, trichomoniasis and syphilis: global prevalence and incidence estimates, 2016. Bull World Health Organ. 2019;97:548.","journal-title":"Bull World Health Organ"},{"key":"12922_CR4","doi-asserted-by":"publisher","first-page":"232","DOI":"10.1097\/OLQ.0000000000001383","volume":"48","author":"FM Lewis","year":"2021","unstructured":"Lewis FM, Spicknall IH, Flagg EW, Papp JR, Kreisel KM. Incidence and Prevalence of Trichomonas vaginalis Infection Among Persons Aged 15 to 59 Years: United States, 2018. Sex Transm Dis. 2021;48:232\u20137.","journal-title":"Sex Transm Dis"},{"key":"12922_CR5","unstructured":"World Health Organization (WHO). Global progress report on HIV, viral hepatitis and sexually transmitted infections, 2021: accountability for the global health sector strategies 2016\u20132021: actions for impact. 2021."},{"key":"12922_CR6","doi-asserted-by":"publisher","first-page":"353","DOI":"10.1097\/00007435-199707000-00008","volume":"24","author":"MF Cotch","year":"1997","unstructured":"Cotch MF, et al. Trichomonas vaginalisassociated with low birth weight and preterm delivery. Sex Transm Dis. 1997;24:353\u201360.","journal-title":"Sex Transm Dis"},{"key":"12922_CR7","first-page":"44","volume":"7","author":"KAH AL-Khalidy","year":"2020","unstructured":"AL-Khalidy KAH, Al-abodi HR. Effect of Vaginal Trichomoniasis on Women who Suffer from Delayed Pregnancy. Eur J Mol Clin Med. 2020;7:44\u20139.","journal-title":"Eur J Mol Clin Med"},{"key":"12922_CR8","doi-asserted-by":"publisher","first-page":"36","DOI":"10.1136\/sextrans-2018-053713","volume":"95","author":"SC Masha","year":"2019","unstructured":"Masha SC, Cools P, Sanders EJ, Vaneechoutte M, Crucitti T. Trichomonas vaginalis and HIV infection acquisition: a systematic review and meta-analysis. Sex Transm Infect. 2019;95:36\u201342.","journal-title":"Sex Transm Infect"},{"key":"12922_CR9","doi-asserted-by":"publisher","first-page":"671","DOI":"10.1097\/OLQ.0b013e3182593839","volume":"39","author":"EB Quinlivan","year":"2012","unstructured":"Quinlivan EB, et al. Modeling the impact of Trichomonas vaginalis infection on HIV transmission in HIV-infected individuals in medical care. Sex Transm Dis. 2012;39:671.","journal-title":"Sex Transm Dis"},{"key":"12922_CR10","doi-asserted-by":"publisher","first-page":"698","DOI":"10.1086\/511278","volume":"195","author":"RS McClelland","year":"2007","unstructured":"McClelland RS, et al. Infection with Trichomonas vaginalis increases the risk of HIV-1 acquisition. J Infect Dis. 2007;195:698\u2013702.","journal-title":"J Infect Dis"},{"key":"12922_CR11","doi-asserted-by":"publisher","first-page":"577","DOI":"10.1093\/oxfordjournals.aje.a116711","volume":"137","author":"F Grodstein","year":"1993","unstructured":"Grodstein F, Goldman MB, Cramer DW. Relation of tubal infertility to history of sexually transmitted diseases. Am J Epidemiol. 1993;137:577\u201384.","journal-title":"Am J Epidemiol"},{"key":"12922_CR12","doi-asserted-by":"publisher","first-page":"2649","DOI":"10.1007\/s00436-020-06759-4","volume":"119","author":"R-Y Su","year":"2020","unstructured":"Su R-Y, et al. Association between Trichomonas vaginalis infection and cervical lesions: a population-based, nested case-control study in Taiwan. Parasitol Res. 2020;119:2649\u201357.","journal-title":"Parasitol Res"},{"key":"12922_CR13","doi-asserted-by":"publisher","first-page":"166","DOI":"10.1016\/j.ejogrb.2018.06.031","volume":"228","author":"S Yang","year":"2018","unstructured":"Yang S, et al. Trichomonas vaginalis infection-associated risk of cervical cancer: A meta-analysis. Eur J Obstet Gynecol Reproductive Biology. 2018;228:166\u201373.","journal-title":"Eur J Obstet Gynecol Reproductive Biology"},{"key":"12922_CR14","doi-asserted-by":"publisher","first-page":"21","DOI":"10.3347\/kjp.2019.57.1.21","volume":"57","author":"J-H Kim","year":"2019","unstructured":"Kim J-H, et al. Comparison of Seropositivity to Trichomonas vaginalis between men with prostatic tumor and Normal men. Korean J Parasitol. 2019;57:21.","journal-title":"Korean J Parasitol"},{"key":"12922_CR15","first-page":"397","volume":"23","author":"AH Ceruelos","year":"2019","unstructured":"Ceruelos AH, Romero-Quezada L, Ledezma JR, Contreras LL. Therapeutic uses of metronidazole and its side effects: an update. Eur Rev Med Pharmacol Sci. 2019;23:397\u2013401.","journal-title":"Eur Rev Med Pharmacol Sci"},{"key":"12922_CR16","doi-asserted-by":"crossref","unstructured":"AlDhaleei W, AlMarzooqi A, Gaber N. Reversible metronidazole-induced neurotoxicity after 10 weeks of therapy. Case Reports. 2018:bcr\u20132017\u2013223463.","DOI":"10.1136\/bcr-2017-223463"},{"key":"12922_CR17","doi-asserted-by":"publisher","first-page":"431","DOI":"10.4103\/ijri.IJRI_330_19","volume":"29","author":"V Vaithiyam","year":"2019","unstructured":"Vaithiyam V, et al. Metronidazole induced encephalopathy: A rare side effect with a common drug. Indian J Radiol Imaging. 2019;29:431.","journal-title":"Indian J Radiol Imaging"},{"key":"12922_CR18","doi-asserted-by":"publisher","first-page":"12628","DOI":"10.1073\/pnas.192301899","volume":"99","author":"S Chernysh","year":"2002","unstructured":"Chernysh S, et al. Antiviral and antitumor peptides from insects. Proc Natl Acad Sci. 2002;99:12628\u201332.","journal-title":"Proc Natl Acad Sci"},{"key":"12922_CR19","doi-asserted-by":"publisher","first-page":"186","DOI":"10.1002\/psc.1219","volume":"16","author":"M Kuczer","year":"2010","unstructured":"Kuczer M, et al. Studies of insect peptides alloferon, Any-GS and their analogues. Synthesis and antiherpes activity. J Pept science: official publication Eur Pept Soc. 2010;16:186\u20139.","journal-title":"J Pept science: official publication Eur Pept Soc"},{"key":"12922_CR20","doi-asserted-by":"publisher","first-page":"110","DOI":"10.1016\/j.imlet.2012.09.005","volume":"149","author":"Y Kim","year":"2013","unstructured":"Kim Y, et al. The anti-inflammatory effect of alloferon on UVB-induced skin inflammation through the down-regulation of pro-inflammatory cytokines. Immunol Lett. 2013;149:110\u20138.","journal-title":"Immunol Lett"},{"key":"12922_CR21","doi-asserted-by":"publisher","first-page":"312","DOI":"10.1016\/j.intimp.2011.10.016","volume":"12","author":"S Chernysh","year":"2012","unstructured":"Chernysh S, Irina K, Irina A. Anti-tumor activity of immunomodulatory peptide alloferon-1 in mouse tumor transplantation model. Int Immunopharmacol. 2012;12:312\u20134.","journal-title":"Int Immunopharmacol"},{"key":"12922_CR22","doi-asserted-by":"publisher","first-page":"1026","DOI":"10.1016\/j.imbio.2012.12.002","volume":"218","author":"S Bae","year":"2013","unstructured":"Bae S, et al. The effect of alloferon on the enhancement of NK cell cytotoxicity against cancer via the up-regulation of perforin\/granzyme B secretion. Immunobiology. 2013;218:1026\u201333.","journal-title":"Immunobiology"},{"key":"12922_CR23","doi-asserted-by":"publisher","first-page":"304","DOI":"10.4110\/in.2015.15.6.304","volume":"15","author":"J Jeon","year":"2015","unstructured":"Jeon J, Kim Y, Kim H, Kang JS, Lee WJ. Anti-inflammatory effect of alloferon on ovalbumin-induced asthma. Immune Netw. 2015;15:304\u201312.","journal-title":"Immune Netw"},{"key":"12922_CR24","doi-asserted-by":"publisher","first-page":"1113","DOI":"10.3390\/biomedicines10051113","volume":"10","author":"H Jo","year":"2022","unstructured":"Jo H, et al. Alloferon Affects the Chemosensitivity of Pancreatic Cancer by Regulating the Expression of SLC6A14. Biomedicines. 2022;10:1113.","journal-title":"Biomedicines"},{"key":"12922_CR25","doi-asserted-by":"publisher","first-page":"552","DOI":"10.2307\/3279345","volume":"61","author":"DG Lindmark","year":"1975","unstructured":"Lindmark DG, M\u00fcller M, Shio H. Hydrogenosomes in Trichomonas vaginalis. J Parasitol. 1975;61:552\u20134.","journal-title":"J Parasitol"},{"key":"12922_CR26","first-page":"2879","volume":"139","author":"M M\u00fcer","year":"1993","unstructured":"M\u00fcer M. The hydrogenosome. Microbiology. 1993;139:2879\u201389.","journal-title":"Microbiology"},{"key":"12922_CR27","doi-asserted-by":"publisher","first-page":"2176","DOI":"10.3390\/microorganisms10112176","volume":"10","author":"M Benchimol","year":"2022","unstructured":"Benchimol M, Gadelha AP, de Souza W. Unusual Cell Structures and Organelles in Giardia intestinalis and Trichomonas vaginalis Are Potential Drug Targets. Microorganisms. 2022;10:2176.","journal-title":"Microorganisms"},{"key":"12922_CR28","unstructured":"Smutn\u00e1 T. Prokaryotic proteins of antioxidant defense in Trichomonas vaginalis hydrogenosomes. 2016."},{"key":"12922_CR29","doi-asserted-by":"publisher","first-page":"657","DOI":"10.1641\/0006-3568(2005)055[0657:HOOMO]2.0.CO;2","volume":"55","author":"N Yarlett","year":"2005","unstructured":"Yarlett N, Hackstein JH. Hydrogenosomes: one organelle, multiple origins. Bioscience. 2005;55:657\u201368.","journal-title":"Bioscience"},{"key":"12922_CR30","doi-asserted-by":"publisher","first-page":"151","DOI":"10.1016\/j.tice.2009.01.001","volume":"41","author":"M Benchimol","year":"2009","unstructured":"Benchimol M. Hydrogenosomes under microscopy. Tissue Cell. 2009;41:151\u201368.","journal-title":"Tissue Cell"},{"key":"12922_CR31","doi-asserted-by":"publisher","first-page":"872","DOI":"10.2174\/138161208784041114","volume":"14","author":"M Benchimol","year":"2008","unstructured":"Benchimol M. The hydrogenosome as a drug target. Curr Pharm Design. 2008;14:872\u201381.","journal-title":"Curr Pharm Design"},{"key":"12922_CR32","doi-asserted-by":"publisher","first-page":"48","DOI":"10.1007\/s13530-014-0187-8","volume":"6","author":"J-H Kim","year":"2014","unstructured":"Kim J-H, Ryu J-S, Lee M-Y. Inhibitory effect of bee venom on the growth of Trichomonas vaginalis. Toxicol Environ Health Sci. 2014;6:48\u201353.","journal-title":"Toxicol Environ Health Sci"},{"key":"12922_CR33","doi-asserted-by":"publisher","first-page":"781","DOI":"10.1080\/14756366.2022.2041629","volume":"37","author":"A Ib\u00e1\u00f1ez-Escribano","year":"2022","unstructured":"Ib\u00e1\u00f1ez-Escribano A, et al. Thio-and selenosemicarbazones as antiprotozoal agents against Trypanosoma cruzi and Trichomonas vaginalis. J Enzyme Inhib Med Chem. 2022;37:781\u201391.","journal-title":"J Enzyme Inhib Med Chem"},{"key":"12922_CR34","doi-asserted-by":"publisher","first-page":"e65148","DOI":"10.1371\/journal.pone.0065148","volume":"8","author":"NC Beltr\u00e1n","year":"2013","unstructured":"Beltr\u00e1n NC, et al. Iron-induced changes in the proteome of Trichomonas vaginalis hydrogenosomes. PLoS ONE. 2013;8:e65148.","journal-title":"PLoS ONE"},{"key":"12922_CR35","doi-asserted-by":"publisher","first-page":"373","DOI":"10.3347\/kjp.2006.44.4.373","volume":"44","author":"Y-S Kim","year":"2006","unstructured":"Kim Y-S, Song H-O, Choi I-H, Park S-J, Ryu J-S. Hydrogenosomal activity of Trichomonas vaginalis cultivated under different iron conditions. Korean J Parasitol. 2006;44:373.","journal-title":"Korean J Parasitol"},{"key":"12922_CR36","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s13071-015-1000-5","volume":"8","author":"W-H Cheng","year":"2015","unstructured":"Cheng W-H, et al. Nitric oxide maintains cell survival of Trichomonas vaginalis upon iron depletion. Parasites vectors. 2015;8:1\u201312.","journal-title":"Parasites vectors"},{"key":"12922_CR37","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1016\/0166-6851(90)90097-6","volume":"41","author":"TA Paget","year":"1990","unstructured":"Paget TA, Lloyd D. Trichomonas vaginalis requires traces of oxygen and high concentrations of carbon dioxide for optimal growth. Mol Biochem Parasitol. 1990;41:65\u201372.","journal-title":"Mol Biochem Parasitol"},{"key":"12922_CR38","doi-asserted-by":"publisher","first-page":"283","DOI":"10.1016\/S0248-4900(03)00060-1","volume":"95","author":"M Benchimol","year":"2003","unstructured":"Benchimol M, Engelke F. Hydrogenosome behavior during the cell cycle in Tritrichomonas foetus. Biol Cell. 2003;95:283\u201393.","journal-title":"Biol Cell"},{"key":"12922_CR39","unstructured":"Benchimol M. Hydrogenosomes and mitosomes: mitochondria of anaerobic eukaryotes. Springer; 2007. pp. 75\u201396."},{"key":"12922_CR40","doi-asserted-by":"crossref","unstructured":"Gorospe CM, et al. Mitochondrial membrane potential acts as a retrograde signal to regulate cell cycle progression. Life Sci Alliance. 2023;6.","DOI":"10.26508\/lsa.202302091"},{"key":"12922_CR41","doi-asserted-by":"publisher","first-page":"1327","DOI":"10.1007\/s10495-016-1295-5","volume":"21","author":"R Horbay","year":"2016","unstructured":"Horbay R, Bilyy R. Mitochondrial dynamics during cell cycling. Apoptosis. 2016;21:1327\u201335.","journal-title":"Apoptosis"},{"key":"12922_CR42","doi-asserted-by":"crossref","unstructured":"Sequeira S, Sousa M, Cruz A. A comprehensive analysis of viability assessment methods for Giardia lamblia and Trichomonas vaginalis: a systematic review. 2023.","DOI":"10.21203\/rs.3.rs-3771752\/v1"},{"key":"12922_CR43","doi-asserted-by":"publisher","first-page":"150","DOI":"10.1128\/CMR.14.1.150-164.2001","volume":"14","author":"P Upcroft","year":"2001","unstructured":"Upcroft P, Upcroft JA. Drug targets and mechanisms of resistance in the anaerobic protozoa. Clin Microbiol Rev. 2001;14:150\u201364.","journal-title":"Clin Microbiol Rev"},{"key":"12922_CR44","doi-asserted-by":"publisher","first-page":"2476","DOI":"10.1128\/AAC.00009-13","volume":"57","author":"N Mallo","year":"2013","unstructured":"Mallo N, Lamas J, Leiro JM. Hydrogenosome metabolism is the key target for antiparasitic activity of resveratrol against Trichomonas vaginalis. Antimicrob Agents Chemother. 2013;57:2476\u201384.","journal-title":"Antimicrob Agents Chemother"},{"key":"12922_CR45","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1007\/s11010-008-9746-0","volume":"313","author":"M-J Ryu","year":"2008","unstructured":"Ryu M-J, et al. Activation of NF-\u03baB by alloferon through down-regulation of antioxidant proteins and I\u03baB\u03b1. Mol Cell Biochem. 2008;313:91\u2013102.","journal-title":"Mol Cell Biochem"},{"key":"12922_CR46","doi-asserted-by":"publisher","first-page":"555","DOI":"10.1089\/ars.2011.4436","volume":"17","author":"C Pal","year":"2012","unstructured":"Pal C, Bandyopadhyay U. Redox-active antiparasitic drugs. Antioxid Redox Signal. 2012;17:555\u201382.","journal-title":"Antioxid Redox Signal"},{"key":"12922_CR47","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1016\/j.molbiopara.2015.01.005","volume":"198","author":"M Uzlikova","year":"2014","unstructured":"Uzlikova M, Nohynkova E. The effect of metronidazole on the cell cycle and DNA in metronidazole-susceptible and-resistant Giardia cell lines. Mol Biochem Parasitol. 2014;198:75\u201381.","journal-title":"Mol Biochem Parasitol"},{"key":"12922_CR48","doi-asserted-by":"publisher","first-page":"125","DOI":"10.1586\/14787210.4.1.125","volume":"4","author":"N Nanda","year":"2006","unstructured":"Nanda N, Michel RG, Kurdgelashvili G, Wendel KA. Trichomoniasis and its treatment. Expert Rev anti-infective therapy. 2006;4:125\u201335.","journal-title":"Expert Rev anti-infective therapy"},{"key":"12922_CR49","doi-asserted-by":"publisher","first-page":"902","DOI":"10.1136\/bmj.2.5203.902","volume":"2","author":"L Watt","year":"1960","unstructured":"Watt L, Jennison R. Clinical evaluation of metronidazole. BMJ. 1960;2:902.","journal-title":"BMJ"},{"key":"12922_CR50","doi-asserted-by":"crossref","unstructured":"Quon D-V, d\u2019Oliveira CE, Johnson PJ. Reduced transcription of the ferredoxin gene in metronidazole-resistant Trichomonas vaginalis. Proc Natl Acad Sci USA. 1992;89:4402\u20134406.","DOI":"10.1073\/pnas.89.10.4402"},{"key":"12922_CR51","doi-asserted-by":"publisher","first-page":"783","DOI":"10.1128\/CMR.17.4.783-793.2004","volume":"17","author":"SL Cudmore","year":"2004","unstructured":"Cudmore SL, Delgaty KL, Hayward-McClelland SF, Petrin DP, Garber GE. Treatment of infections caused by metronidazole-resistant Trichomonas vaginalis. Clin Microbiol Rev. 2004;17:783\u201393.","journal-title":"Clin Microbiol Rev"},{"key":"12922_CR52","doi-asserted-by":"publisher","first-page":"38022","DOI":"10.18632\/oncotarget.16723","volume":"8","author":"RB Mokhtari","year":"2017","unstructured":"Mokhtari RB, et al. Combination therapy in combating cancer. Oncotarget. 2017;8:38022.","journal-title":"Oncotarget"},{"key":"12922_CR53","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s13045-021-01164-5","volume":"14","author":"S Zhu","year":"2021","unstructured":"Zhu S, et al. Combination strategies to maximize the benefits of cancer immunotherapy. J Hematol Oncol. 2021;14:1\u201333.","journal-title":"J Hematol Oncol"},{"key":"12922_CR54","doi-asserted-by":"publisher","first-page":"345","DOI":"10.1159\/000238292","volume":"30","author":"M Schneider","year":"1984","unstructured":"Schneider M, Riemann J, Laudage G. Serum concentrations of metronidazole and its main metabolite in patients with active Crohn\u2019s disease: correlation with disease activity and therapeutic efficacy? Chemotherapy. 1984;30:345\u201352.","journal-title":"Chemotherapy"}],"container-title":["BMC Infectious Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12879-026-12922-6","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12879-026-12922-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12879-026-12922-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,24]],"date-time":"2026-04-24T03:44:08Z","timestamp":1777002248000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s12879-026-12922-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,3,17]]},"references-count":54,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["12922"],"URL":"https:\/\/doi.org\/10.1186\/s12879-026-12922-6","relation":{},"ISSN":["1471-2334"],"issn-type":[{"value":"1471-2334","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,3,17]]},"assertion":[{"value":"13 October 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 February 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 March 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"826"}}